01.11.2014 Views

Biosafety in the laboratory - VIB

Biosafety in the laboratory - VIB

Biosafety in the laboratory - VIB

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Work<strong>in</strong>g with genetically modified viruses or viral vectors<br />

Classification<br />

Genetically modified viruses are generally classified <strong>in</strong> <strong>the</strong> same risk class as <strong>the</strong>ir biological<br />

counterparts (see <strong>the</strong> annexes to Vlarem II (www.biosafety.be)), unless <strong>the</strong> <strong>in</strong>sert <strong>in</strong>creases<br />

<strong>the</strong> risk. In <strong>the</strong> latter case <strong>the</strong> modified virus will be classified at a higher risk level than its<br />

biological counterpart. The use of viruses and viral vectors cannot be detached from <strong>the</strong><br />

use of cell l<strong>in</strong>es. This implies that here too <strong>the</strong> comb<strong>in</strong>ation of viral sequences <strong>in</strong> <strong>the</strong> vector<br />

and <strong>in</strong> <strong>the</strong> cell l<strong>in</strong>e should be considered. To produce replication-defective virus particles,<br />

cell l<strong>in</strong>es conta<strong>in</strong><strong>in</strong>g <strong>the</strong> miss<strong>in</strong>g viral sequences needed to create virus particles are<br />

used. Only when <strong>the</strong>re is no risk that replication-competent virus particles might be formed,<br />

<strong>the</strong> virus can be classified at a lower level.<br />

Packag<strong>in</strong>g Viral sequences Vector (by way Classification* Classification Comments<br />

cell l<strong>in</strong>e <strong>in</strong> <strong>the</strong> cell l<strong>in</strong>e of example only) rule**<br />

293 E1 and piece of E1 deleted L2 8 e or j Comb<strong>in</strong>ation of<br />

E4 gene from adenoviral viral sequences <strong>in</strong><br />

adenovirus vector cell l<strong>in</strong>e and vector<br />

may result <strong>in</strong> <strong>the</strong><br />

formation of a<br />

replicationcompetent<br />

virus<br />

PER.C6 E1 gene from E1 deleted L1 9 e or j Zero risk of replicaadenovirus<br />

adenoviral vector tion-competent virus<br />

with no sequence<br />

particle formation<br />

overlap<br />

PA317 Gag-pol-env from Retroviral vector L2 8 e or j Small risk of RCR<br />

amphotrophic lack<strong>in</strong>g <strong>the</strong> formation, though<br />

mouse retrovirus gag-pol-env not unlikely.<br />

genes<br />

Sequence overlap<br />

occurs <strong>in</strong> many cases<br />

psi-CRE Gag-pol and env Retroviral vector L1 7 e or j Risk of RCR formagenes<br />

from lack<strong>in</strong>g <strong>the</strong> tion is smaller than<br />

ecotropic mouse gag-pol-env with PA317.<br />

retrovirus as two genes Moreover, <strong>the</strong> virus<br />

separate constructs<br />

is ecotropic and<br />

<strong>the</strong>refore unable to<br />

<strong>in</strong>fect human cells.<br />

Phoenix- E1/E4 from Retroviral vector L2 8 e or j Risk of RCR formaampho<br />

adenovirus, SV40 lack<strong>in</strong>g <strong>the</strong> tion is smaller than<br />

large T and Gag-pol-env with PA317, but not<br />

episomal gag-pol genes zero, due to <strong>the</strong> epiand<br />

env genes from<br />

amphotrophic<br />

mouse retrovirus<br />

somal presence of<br />

gag-pol and env <strong>in</strong><br />

multiple copies<br />

* on <strong>the</strong> assumption that non-hazardous <strong>in</strong>serts are used (hazardous <strong>in</strong>serts would require a higher risk class)<br />

** as applied <strong>in</strong> <strong>the</strong> schemes of annex 2<br />

Work<strong>in</strong>g with commonly used <strong>laboratory</strong> organisms 41

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!